The Influence of Pre-Existing Beta-Blockers Use on Survival Outcomes in HER2 Positive Advanced Breast Cancer: Pooled Analysis of Clinical Trial Data

Introduction: Beta-blockers (BB) are commonly used to manage cardiovascular disease and may have benefits in controlling complications of anti-HER2 therapies. This study aimed to evaluate the association of pre-existing BB use with survival outcomes in patients initiating anti-HER2 therapy for advan...

Descripción completa

Detalles Bibliográficos
Autores principales: Modi, Natansh D., Tan, Jin Quan Eugene, Rowland, Andrew, Koczwara, Bogda, Kichenadasse, Ganessan, McKinnon, Ross A., Wiese, Michael D., Sorich, Michael J., Hopkins, Ashley M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373122/
https://www.ncbi.nlm.nih.gov/pubmed/32760671
http://dx.doi.org/10.3389/fonc.2020.01130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373122/
https://www.ncbi.nlm.nih.gov/pubmed/32760671
http://dx.doi.org/10.3389/fonc.2020.01130

Ejemplares similares